Skip to main content
$60.28 -$0.51 (-0.8%)

04:00 PM EDT on 08/04/21

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

CAPS Rating: No stars

Current Price $60.28 Mkt Cap $2.7B
Open $60.05 P/E Ratio 17.59
Prev. Close $60.28 Div. (Yield) $0.00 (0.0%)
Daily Range $58.54 - $61.38 Volume 493,801
52-Wk Range $48.23 - $80.00 Avg. Daily Vol. 389,572

Caps

How do you think NASDAQ:PCRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

53 Outperform
11 Underperform
 

All-Star Players

6 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:PCRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFSarahGen (97.78)
Submitted August 04, 2016

non opioid pain meds

zzlangerhans (98.46)
Submitted January 20, 2012

The commercial success of Exparel is a tough call to make. Intuitively, the drug seems to be filling an important niche in post-operative pain management. But empirical evidence tells us that launches of new drugs are usually slow, and expecially in… More

NASDAQ:PCRX VS S&P 500 (SPY)

Fools bullish on NASDAQ:PCRX are also bullish on:

Fools bearish on NASDAQ:PCRX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PCRX.

Recs

0
Member Avatar TMFjimhalley (40.55) Submitted: 3/24/2021 9:52:51 AM : Outperform Start Price: $70.14 NASDAQ:PCRX Score: -26.38

The company will benefit from the expanded label of its lead drug, Exparel, In addition, many elective surgeries that were put off during the pandemic will likely happen once it ebbs later this year, increasing business for Pacira.

Recs

0
Member Avatar jonnycd (< 20) Submitted: 2/24/2021 10:57:39 AM : Outperform Start Price: $77.62 NASDAQ:PCRX Score: -35.37

Great product that not being fully utilized yet

Recs

1
Member Avatar TMFSarahGen (97.78) Submitted: 8/4/2016 2:50:53 PM : Outperform Start Price: $44.87 NASDAQ:PCRX Score: -68.62

non opioid pain meds

Leaderboard

Find the members with the highest scoring picks in PCRX.

Score Leader

IPOMizzouFanVan

IPOMizzouFanVan (65.96) Score: +528.39

The Score Leader is the player with the highest score across all their picks in PCRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
IPOMizzouFanVan 65.96 2/7/2011 Outperform 3Y $7.01 +760.53% +232.14% +528.39 0 Comment
ChristopherHamel 63.31 11/28/2011 Outperform 5Y $7.25 +731.45% +267.26% +464.19 0 Comment
locochango 87.57 11/7/2011 Outperform 5Y $7.66 +686.95% +250.12% +436.82 0 Comment
PatientTrader < 20 11/2/2011 Outperform 5Y $8.89 +578.07% +253.93% +324.13 0 Comment
FUZZYMINKINS < 20 8/1/2011 Outperform 5Y $10.06 +499.20% +235.54% +263.67 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. schwein2010 20.60 9/19/2011 5/8/2013 Outperform 5Y $10.58 +469.75% +264.88% +204.88 0 Comment
PharmaD < 20 10/27/2011 7/17/2012 Outperform 3Y $11.39 +429.24% +243.98% +185.26 2 Comments
wahodges 87.06 5/19/2014 Underperform 5Y $75.09 -19.72% +133.91% +153.63 0 Comment
CocaineOrStock 92.49 7/15/2014 Underperform 5Y $86.81 -30.56% +122.48% +153.04 0 Comment
jsrichards < 20 6/11/2012 Outperform 3Y $13.06 +361.56% +231.64% +129.93 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PCRX.